296 related articles for article (PubMed ID: 16677369)
21. Accidental busulfan overdose: enhanced drug clearance with hemodialysis in a child with Wiskott-Aldrich syndrome.
Stein J; Davidovitz M; Yaniv I; Ben-Ari J; Gamzu Z; Hoffer E; Bentur Y; Tabak A; Krivoy N
Bone Marrow Transplant; 2001 Mar; 27(5):551-3. PubMed ID: 11313692
[TBL] [Abstract][Full Text] [Related]
22. Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation.
Parkman R; Rappeport J; Geha R; Belli J; Cassady R; Levey R; Nathan DG; Rosen FS
N Engl J Med; 1978 Apr; 298(17):921-7. PubMed ID: 347289
[TBL] [Abstract][Full Text] [Related]
23. Successful allogeneic peripheral blood stem cell transplantation in Wiskott-Aldrich Syndrome Patients: first report in Thailand.
Hongeng S; Benjaponpitak S; Tardtong P; Varavithya W; Chuansumrit A; Chunharas A; Chaisiripoomkere W; Hathira P
Asian Pac J Allergy Immunol; 2001 Sep; 19(3):191-5. PubMed ID: 11826914
[TBL] [Abstract][Full Text] [Related]
24. Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study.
Moratto D; Giliani S; Bonfim C; Mazzolari E; Fischer A; Ochs HD; Cant AJ; Thrasher AJ; Cowan MJ; Albert MH; Small T; Pai SY; Haddad E; Lisa A; Hambleton S; Slatter M; Cavazzana-Calvo M; Mahlaoui N; Picard C; Torgerson TR; Burroughs L; Koliski A; Neto JZ; Porta F; Qasim W; Veys P; Kavanau K; Hönig M; Schulz A; Friedrich W; Notarangelo LD
Blood; 2011 Aug; 118(6):1675-84. PubMed ID: 21659547
[TBL] [Abstract][Full Text] [Related]
25. Successful allogeneic stem cell transplantation with a reduced-intensity conditioning in a leukocyte adhesion deficiency type I patient.
Hamidieh AA; Pourpak Z; Alimoghaddam K; Movahedi M; Bahoush G; Behmanesh F; Moin M; Ghavamzadeh A
Pediatr Transplant; 2011 Mar; 15(2):E30-3. PubMed ID: 19912557
[TBL] [Abstract][Full Text] [Related]
26. Umbilical cord blood transplantation in Wiskott Aldrich syndrome.
Knutsen AP; Steffen M; Wassmer K; Wall DA
J Pediatr; 2003 May; 142(5):519-23. PubMed ID: 12756384
[TBL] [Abstract][Full Text] [Related]
27. Engraftment kinetics and hematopoietic chimerism after reduced-intensity conditioning with fludarabine and treosulfan before allogeneic stem cell transplantation.
Blau IW; Schmidt-Hieber M; Leschinger N; Göldner H; Knauf W; Hopfenmüller W; Thiel E; Blau O
Ann Hematol; 2007 Aug; 86(8):583-9. PubMed ID: 17468869
[TBL] [Abstract][Full Text] [Related]
28. Split chimerism after allogeneic bone marrow transplantation in Chediak-Higashi syndrome.
Yamazaki S; Takahashi H; Fujii H; Miyamae T; Mori M; Fujioka K; Funabiki T; Yokota S; Arai N; Ikuta K
Bone Marrow Transplant; 2003 Jan; 31(2):137-40. PubMed ID: 12621497
[TBL] [Abstract][Full Text] [Related]
29. Platelet glycoprotein complex Ia/IIa antibodies cause neonatal alloimmune thrombocytopenia but do not inhibit megakaryopoiesis and platelet recovery after allogeneic cord blood stem cell transplantation.
Cassens U; Garritsen H; Kelsch R; van der Werf N; Frosch M; Witteler R; Ebell W; Sibrowski W
Bone Marrow Transplant; 2001 Oct; 28(8):803-6. PubMed ID: 11781636
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous manifestations in patients with Wiskott-Aldrich syndrome submitted to haematopoietic stem cell transplantation.
Loyola Presa JG; de Carvalho VO; Morrisey LR; Bonfim CM; Abagge KT; Vasselai A; Marinoni LP
Arch Dis Child; 2013 Apr; 98(4):304-7. PubMed ID: 23343520
[TBL] [Abstract][Full Text] [Related]
31. A case of Wiskott-Aldrich syndrome with de novo mutation at exon 4.
Doğu F; Ariga T; Ikincioğullari A; Bozdoğan G; Aytekin C; Metin A; Babacan E
Turk J Pediatr; 2006; 48(1):66-8. PubMed ID: 16562789
[TBL] [Abstract][Full Text] [Related]
32. Outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome.
Shin CR; Kim MO; Li D; Bleesing JJ; Harris R; Mehta P; Jodele S; Jordan MB; Marsh RA; Davies SM; Filipovich AH
Bone Marrow Transplant; 2012 Nov; 47(11):1428-35. PubMed ID: 22426750
[TBL] [Abstract][Full Text] [Related]
33. [Hematopoietic stem cell transplantation for patients with Wiskott-Aldrich syndrome].
Wietstruck P MA; Zúñiga C P; Talesnik G E; Méndez R C; Barriga C F
Rev Med Chil; 2007 Jul; 135(7):917-23. PubMed ID: 17914550
[TBL] [Abstract][Full Text] [Related]
34. Hematopoietic stem cell transplantation for X-linked thrombocytopenia from a mild symptomatic carrier.
Okuya M; Kurosawa H; Kubota T; Endoh K; Ogiwara A; Nonoyama S; Hagisawa S; Sato Y; Matsushita T; Fukushima K; Sugita K; Sato T; Arisaka O
Bone Marrow Transplant; 2010 Mar; 45(3):607-9. PubMed ID: 19684625
[No Abstract] [Full Text] [Related]
35. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
Strober S
Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
[TBL] [Abstract][Full Text] [Related]
36. Unrelated cord blood transplantation for severe combined immunodeficiency and other primary immunodeficiencies.
Díaz de Heredia C; Ortega JJ; Díaz MA; Olivé T; Badell I; González-Vicent M; Sánchez de Toledo J
Bone Marrow Transplant; 2008 Apr; 41(7):627-33. PubMed ID: 18084339
[TBL] [Abstract][Full Text] [Related]
37. Allogeneic peripheral blood stem cell transplantation in a Wiskott-Aldrich syndrome patient.
Hongeng S; Pakakasama S; Hathirat P; Chaisiripoomkere W; Ungkanont A
Bone Marrow Transplant; 1999 Aug; 24(4):445-6. PubMed ID: 10467341
[No Abstract] [Full Text] [Related]
38. Outcomes of hematopoietic stem cell transplantation in primary immunodeficiency: a report from the Australian and New Zealand Children's Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry.
Mitchell R; Nivison-Smith I; Anazodo A; Tiedemann K; Shaw P; Teague L; Fraser C; Carter T; Tapp H; Alvaro F; O'Brien TA
Biol Blood Marrow Transplant; 2013 Mar; 19(3):338-43. PubMed ID: 23228588
[TBL] [Abstract][Full Text] [Related]
39. Splenectomy in the management of the thrombocytopenia of the Wiskott-Aldrich syndrome.
Lum LG; Tubergen DG; Corash L; Blaese RM
N Engl J Med; 1980 Apr; 302(16):892-6. PubMed ID: 6767187
[TBL] [Abstract][Full Text] [Related]
40. Substitution of cyclophosphamide and busulfan by fludarabine, treosulfan and melphalan in a preparative regimen for children and adolescents with Shwachman-Diamond syndrome.
Sauer M; Zeidler C; Meissner B; Rehe K; Hanke A; Welte K; Lohse P; Sykora KW
Bone Marrow Transplant; 2007 Feb; 39(3):143-7. PubMed ID: 17211437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
